Wockridge Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 07-01-2025
- Paid Up Capital ₹ 0.10 M
as on 07-01-2025
- Company Age 6 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Revenue %
(FY 2020)
- Profit -15.00%
(FY 2020)
- Ebitda -15.00%
(FY 2020)
- Net Worth -21.90%
(FY 2020)
- Total Assets -21.90%
(FY 2020)
About Wockridge Pharma
The Company is engaged in the Research & Development Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Sowjanya Tamma and Rajasekhara Tamma serve as directors at the Company.
- CIN/LLPIN
U73100TG2018PTC122935
- Company No.
122935
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Mar 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Wockridge Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sowjanya Tamma  | Director | 13-Mar-2018 | Current |
| Rajasekhara Tamma | Director | 13-Mar-2018 | Current |
Financial Performance of Wockridge Pharma.
Wockridge Pharma Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 15% decrease in profit. The company's net worth observed a substantial decline by a decrease of 21.9%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Wockridge Pharma?
Unlock access to Wockridge Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Blue Bricks Ventures Private LimitedActive 4 months 9 daysSowjanya Tamma and Rajasekhara Tamma are mutual person
- Wockridge Global Healthcare Private LimitedActive 5 years 1 month
Sowjanya Tamma and Rajasekhara Tamma are mutual person
- Clinwave Research Private LimitedActive 6 years 10 months
Sowjanya Tamma and Rajasekhara Tamma are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Wockridge Pharma?
Unlock and access historical data on people associated with Wockridge Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Wockridge Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Wockridge Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
